Organisms | Evidence |
---|---|
Aspergillus awamori |
UniProt ID | Protein Name | Reference | Source |
---|---|---|---|
O54088 | Cytochrome b558/566 subunit A | ||
P00590 | Cutinase 1 | ||
P07996 | Thrombospondin-1 | ||
P10153 | Non-secretory ribonuclease | ||
P23176 | Glucoamylase I | ||
P29460 | Interleukin-12 subunit beta | ||
P69327 | Glucoamylase | ||
P69328 | Glucoamylase |
Pathway Name | Organism |
---|---|
Lysosomal oligosaccharide catabolism | Canis familiaris |
Lysosomal oligosaccharide catabolism | Gallus gallus |
Lysosomal oligosaccharide catabolism | Schizosaccharomyces pombe |
Lysosomal oligosaccharide catabolism | Danio rerio |
Progressive trimming of alpha-1,2-linked mannose residues from Man9/8/7GlcNAc2 to produce Man5GlcNAc2 | Xenopus tropicalis |
Progressive trimming of alpha-1,2-linked mannose residues from Man9/8/7GlcNAc2 to produce Man5GlcNAc2 | Bos taurus |
Progressive trimming of alpha-1,2-linked mannose residues from Man9/8/7GlcNAc2 to produce Man5GlcNAc2 | Danio rerio |
Progressive trimming of alpha-1,2-linked mannose residues from Man9/8/7GlcNAc2 to produce Man5GlcNAc2 | Canis familiaris |
Progressive trimming of alpha-1,2-linked mannose residues from Man9/8/7GlcNAc2 to produce Man5GlcNAc2 | Caenorhabditis elegans |
Progressive trimming of alpha-1,2-linked mannose residues from Man9/8/7GlcNAc2 to produce Man5GlcNAc2 | Gallus gallus |
RES 1b:x-dman-HEX-1:5
PubMed ID | Title | First Author | Publication Date | Source |
---|---|---|---|---|
38708720 | Conserved cysteines prevent C‐mannosylation of mucin Cys domains | Albers MD | 2024 May 06 |
|
38637262 | Randomized clinical trial of non-antibiotic prophylaxis with d-Mannose plus Proanthocyanidins vs. Proanthocyanidins alone for urinary tract infections and asymptomatic bacteriuria in de novo kidney transplant recipients: The Manotras study | Rau M | 2024 May |
|
38554019 | MANNosylation of Mesoporous Silica Nanoparticles Modifies TLR4 Localization and NF‐κB Translocation in T24 Bladder Cancer Cells | Hohagen M | 2024 Mar 30 |
|
38532026 | Macrophage mannose receptor CD206 targeting of fluoride-18 labeled mannosylated dextran: A validation study in mice | Andriana P | 2024 Mar 27 |
|
38410093 | Trap & kill: a neutrophil-extracellular-trap mimic nanoparticle for anti-bacterial therapy | Zheng J | 2024 Mar 26 |
|
38478917 | Anticancer and Antibacterial Properties of Curcumin-Loaded Mannosylated Solid Lipid Nanoparticles for the Treatment of Lung Diseases | Chae J | 2024 Mar 13 |
|
38533506 | Engineered therapeutic antibodies with mannose 6-phosphate analogues as a tool to degrade extracellular proteins | Daurat M | 2024 Mar 12 |
|
38329387 | Preparation of glycopeptide-modified pH-sensitive liposomes for promoting antigen cross-presentation and induction of antigen-specific cellular immunity | Yuba E | 2024 Mar 12 |
|
38529272 | Mannose enhances intestinal immune barrier function and dextran sulfate sodium salt-induced colitis in mice by regulating intestinal microbiota | Yang Y | 2024 Mar 11 |
|
38340899 | Maduramycin, a novel glycosylation modulator for mammalian fed-batch and steady-state perfusion processes | Romann P | 2024 Mar 10 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.2.1
Last updated: April 7, 2025